|
| |
Iomai Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Bioentrepreneur - Bioe News - MedImmune Ventures plumps for Iomai
In this case, MedImmune has its eye on Iomai's transcutaneous drug delivery ... Iomai. Merck & Co, Merck Capital Ventures, 2000, 120, Technologies that ...
http://www.nature.com/bioent/bioenews/022003/full/bioent718....
|
Summary of IOMAI CORP - Yahoo! Finance
On June 2, 2008, Iomai Corporation ("Iomai") received notice that the U.S. Department of Justice and Federal Trade Commission have granted early
termination ...
http://biz.yahoo.com/e/080603/iomi8-k.html...
|
BioPortfolio - Iomai - Profile
Iomai Corporation discovers and develops vaccines and immune system stimulants, ... Iomai is leveraging TCI to enhance the efficacy of existing vaccines, ...
http://www.bioportfolio.com/biocorporate/5851-Iomai.pdf...
|
Summary of IOMAI CORP - Yahoo! Finance
On June 16, 2008, Iomai Corporation ("Iomai") received notice that the Committee on Foreign Investment in the United States ("CFIUS") of the U.S. Department ...
http://biz.yahoo.com/e/080618/iomi8-k.html...
|
Iomai Appoints Thomas Martin Vernon, Jr., M.D. and F. Weller Meyer ...
I also want to thank Jim Young for his major contributions to Iomai and recognize his dedication to the Board since joining in 2002. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
BioSpace - IOMAI Corporation News, Search Jobs, Events
IOMAI Corporation 20 Firstfield Road, Suite 250. Gaithersburg Maryland 20878 U.S.A.. Phone: 301-556-4500 Fax: 301-556-4501 ...
http://www.biospace.com/company_profile.aspx?CompanyId=28360...
|
MedImmune Ventures plumps for Iomai : Article : Bioentrepreneur
In this case, MedImmune has its eye on Iomai's transcutaneous drug delivery technology, which enables delivery of vaccines to the skin through a patch. ...
http://www.nature.com/bioent/2003/030201/full/bioent718.html...
|
IOMAI Corporation Shows Dry Vaccine Patch Is Effective - News ...
COVENTRY, England, April 6 /PRNewswire-FirstCall/ -- Iomai Corporation announced today the completion of a Phase 1/2 clinical trial in which its dry vaccine ...
http://www.biospace.com/news_story.aspx?NewsEntityId=14631...
|
Intercell AG to Acquire Iomai Corporation to Expand Late Stage ...
Intercell AG ('Intercell') to acquire Iomai Corporation ('Iomai') in a fully recommended share/cash transaction for USD 6.60 per share of Iomai's common ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
IOMAI Corporation Wins Department of Defense Grant to Develop a ...
GAITHERSBURG, Md., April 8, 2008 /PRNewswire-FirstCall/ -- Iomai Corporation today announced it will receive a cost-reimbursement grant for up to $943856 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=91984...
|
|
